An official website of the United States government
Here's how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Brought to you by the Council of the Inspectors General on Integrity and Efficiency
Federal Reports
Report Date
Agency Reviewed / Investigated
Report Title
Type
Location
Committee for Purchase From People Who Are Blind or Severely Disabled (AbilityOne Program)
Top Management and Performance Challenges for Fiscal Year 2026
In accordance with the Reports Consolidation Act of 2000, the Office of Inspector General (OIG) is reporting what it has determined are the most pressing management and performance challenges facing the U.S. AbilityOne Commission (Commission) for fiscal year (FY) 2026. This report provides our views on these challenges for inclusion in the Commission’s Performance and Accountability Report (PAR) for FY 2026.
Management and performance challenges are based on the OIG’s observations from the work performed as well as information obtained while conducting oversight activities. The OIG identified these challenges based on the results and findings of its oversight, including audits, evaluations, and investigative activities. as well as information uncovered while conducting oversight. • Enhancing Information Technology • Modernizing the Program • Strengthening Human Capital
Addressing these challenges will enhance the Commission’s efficiency and effectiveness in meeting the mission and goals of the AbilityOne Program.
The U.S. Environmental Protection Agency Office of Inspector General conducted this audit to determine whether the EPA has sufficient controls over its grants management processes to monitor post-award performance of grants awarded with Infrastructure Investment and Jobs Act funding in accordance with federal grant requirements and other related EPA policies.
Summary of Findings
The EPA did not have controls in place to ensure that its regional offices are monitoring post-award performance of grants through required post-award monitoring plans and regular monitoring reviews. In addition, the regional offices did not always complete their baseline monitoring reports. Finally, of the 40 grant files we reviewed, 39 were not maintained in accordance with regional policy.
VHA pharmacies cannot dispense drugs that are damaged or expired or will be expiring soon. To address this issue and to recover some costs, VA contracted with Pharma Logistics LLC to provide national reverse distribution services, where manufacturers accept returned drugs in exchange for credits toward future purchases. Pharma Logistics collected returned drugs, sorted them, returned them to the manufacturers, disposed of nonreturnable products, and coordinated the application of credits from manufacturers to VA accounts. The OIG’s objective was to determine whether Pharma Logistics complied, in all material respects, with its contract regarding drug return credits and billing. Of the about $114.4 million in manufacturer credits for drugs that VA facilities expected from reverse distribution services as of March 2024, VA received only about $110.3 million. Of the $4.1 million variance, over $3.6 million of the unapplied credits were related to Pharma Logistics improperly closing jobs and $526,520 was used for contract-prohibited processing fees. VA agreed with the OIG’s three recommendations for it to confer with VA’s Office of General Counsel regarding the potential recovery of credits.
